Clinical Study on Amavata (Rheumatoid Arthritis) with Simhanada Guggulu and Shatapuspadi Lepa

Authors

  • Saroj Kumar Debnath
  • Sudhaben N Vyas

Keywords:

Amavata, Rheumatoid arthritis, Female, 30 to 50 years, Simhanada guggulu, Shatapushpadi lepa

Abstract

In the present clinical study 46 Amavata (Rheumatoid arthritis) patients were registered from the O.P.D. & I.P.D., Department of Kayachikitsa (General Medicine), Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Jamnagar. 40 patients completed the treatment out of 46 and 6 patients left the treatment before completion of the therapy. The aim of the study was to evaluate the role of selected Ayurvedic medicines on the management of Amavata (Rheumatoid arthritis). The treatment schedule was that 1gm Simhanada guggulu (Ayurvedic pill medicine) orally thrice in a day with warm water for 45 days & Shatapushpadi lepa (Ayurvedic paste medicine) applied locally over affected joints mixed with warm water twice in a day for 45 days. In present clinical study 40 % patients showed major improvement, 50% patients showed minor improvement, 10% patients showed no improvement and no one patient had got complete remission. No adverse drug reaction was found in this clinical study.

Downloads

Published

2014-05-09

How to Cite

Debnath, S. K., & Vyas, S. N. (2014). Clinical Study on Amavata (Rheumatoid Arthritis) with Simhanada Guggulu and Shatapuspadi Lepa. International Journal of Ayurvedic Medicine, 5(1). Retrieved from https://ijam.co.in/index.php/ijam/article/view/05062014

Issue

Vol. 5 No. 1 (2014): January - March 2014

Section

Research Articles

License

The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.

This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.

The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

https://creativecommons.org/licenses/by-nc-sa/4.0/